Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11.11. | Encode Ideas, L.P. Announces the Initiation of Research Coverage on ESSA Pharma, Inc. | 814 | Newsfile | Dover, Delaware--(Newsfile Corp. - November 11, 2019) - Encode Ideas, L.P. Initiates Research on ESSA Pharma, Inc. (NASDAQ: EPIX). The full research publication is available here and available on our... ► Artikel lesen | |
30.10. | Essa Pharma Inc (2): Essa Pharma grants options to buy 225,000 shares | - | Stockwatch | ||
30.10. | ESSA Pharma Grants Stock Options | - | CNW | ||
ESSA PHARMA Aktien jetzt im kostenlosen Demokonto handeln! | |||||
28.10. | ESSA Pharma Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
18.10. | ESSA Pharma Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
18.10. | Essa Pharma Inc (2): Essa appoints Brettman as director; Stampacchia resigns | - | Stockwatch | ||
11.10. | ESSA Pharma: Promising Novel Therapy For Treatment Of Prostate Cancer | - | Seeking Alpha | ||
07.10. | ESSA Pharma Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
07.10. | ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants | - | CNW | ||
07.10. | Essa Pharma Inc (2): Essa Pharma grants options to buy 1.44 million shares | - | Stockwatch | ||
30.09. | ESSA Pharma Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
28.09. | ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress | 1 | CNW | ||
19.09. | ESSA Pharma Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
18.09. | Essa Pharma Inc (2): Essa Pharma 6,080,596-share prospectus offering | - | Stockwatch | ||
05.09. | ESSA Pharma Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
27.08. | ESSA Pharma closes $36M capital raise | - | Seeking Alpha | ||
27.08. | Essa Pharma Inc (2): Essa Pharma closes $36-million (U.S.) in financings | - | Stockwatch | ||
27.08. | ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million | - | CNW | ||
23.08. | ESSA Pharma Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
23.08. | ESSA Pharma up 3% on bullish pricing of equity offering | - | Seeking Alpha |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
HALO LABS | 0,222 | -3,48 % | HOT! Meilenstein angekündigt - Der große Ausbruch und Rallye!? | ||
CURASAN | 1,030 | +7,29 % | Original-Research: curasan AG (von Montega AG): Kaufen | Original-Research: curasan AG - von Montega AG
Einstufung von Montega AG zu curasan AG
Unternehmen: curasan AG
ISIN: DE000A2YPGM4
Anlass der Studie: Update
Empfehlung: Kaufen
seit:... ► Artikel lesen | |
CALLITAS HEALTH | 0,075 | -100,00 % | XFRA T3F3: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL CALLITAS HEALTH... ► Artikel lesen | |
ORGANIGRAM | 2,413 | -0,37 % | Cannabis in Europa - Wissensserie: Italien | ||
VERITAS PHARMA | 0,102 | +7,37 % | Veritas Pharma Inc. Announces the Sale of the Sechelt Property | Vancouver, British Columbia--(Newsfile Corp. - December 9, 2019) - Veritas Pharma Inc.'s (CSE: VRT) (OTC: VRTHF) (Frankfurt: 2VP) ("Veritas" or the "Company") is pleased to announce that its fully owned... ► Artikel lesen | |
AMARIN | 20,600 | 0,00 % | Amarin Corporation plc: Europäischen Arzneimittelagentur akzeptiert Prüfung des Antrags auf Genehmigung für das Inverkehrbringen von Amarins Icosapent-Ethyl (Vascepa) zur Reduzierung des kardiovaskulären Risikos für Hochrisikopatienten gemäß der REDUCE-IT | DUBLIN, Irland und BRIDGEWATER, New Jersey, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), ein Pharmaunternehmen, das seinen Schwerpunkt auf der Verbesserung der kardiovaskulären... ► Artikel lesen | |
INTEGRATED CANNABIS | 0,092 | -2,13 % | Cannabis One Holdings Inc. and ONE Cannabis Group to Combine, Forming the First US-Based Vertically Integrated Cannabis Franchise and Brand Company | Vancouver, British Columbia and Denver, Colorado--(Newsfile Corp. - December 10, 2019) - Cannabis One Holdings Inc. (CSE: CBIS) ("Cannabis One", "CBIS" or the "Company"), today announced that it has... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 4,100 | -0,97 % | Oramed's trial results push share price up 80% | ||
OPKO HEALTH | 1,425 | -0,70 % | OPKO Health wechselt zum mehrkanaligen Kundenbeziehungsmanagement (Customer Relationship Management, CRM) von Veeva, um eine effektivere Kundenbindung voranzutreiben | Das CRM von Veeva gibt pharmazeutischen Außendienstmitarbeitern die richtigen Informationen an die Hand, die sie brauchen, um eine personalisierte Kundenerfahrung zu bieten Veeva Systems (NYSE:VEEV)... ► Artikel lesen | |
INSYS THERAPEUTICS | 0,050 | 0,00 % | Insys sieht sich als Bindeglied zwischen Industrie und IT: Der bayrische Hersteller Insys Icom stattet die Industrie ... | ||
PERRIGO | 47,600 | +0,42 % | Perrigo (PRGO) Presents At Morgan Stanley Global Consumer and Retail Conference - Slideshow | ||
SAVARA | 1,080 | +1,89 % | Savara Inc - 8-K, Current Report | ||
SOLIGENIX | 0,920 | -8,91 % | Soligenix completes patient enrollment late-stage CTCL study | ||
ADAMIS PHARMACEUTICALS | 0,500 | -0,99 % | XFRA CY3B: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT... ► Artikel lesen | |
VODIS | 0,025 | +6,52 % | Vodis Pharmaceuticals Inc (2): Vodis CTO issued by BCSC revoked |